Pular para o conteúdo
Ataxia rara
ORPHA:102002CID-10 · G11.1DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Dermatológico

Síndrome neurológica caracterizada por movimentos desajeitados e descoordenados dos membros, tronco e músculos cranianos. Resulta de patologia no cerebelo e suas conexões, ou nas vias sensoriais proprioceptivas.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A ataxia rara é uma condição neurológica que afeta o cerebelo e as vias sensoriais, provocando movimentos desajeitados e falta de coordenação no corpo. A família costuma notar sintomas como atraso na habilidade de caminhar, movimentos involuntários e dificuldades na fala. A condição está ligada a mutações em múltiplos genes importantes, como ATG7, TWNK e SPTBN2. A doença não possui Protocolo Clínico e Diretrizes Terapêuticas (PCDT) oficial no SUS, e medicamentos registrados na ANVISA, como o riluzol, não têm dispensação pública regular estabelecida para esta categoria.

📋
Informacoes curadas por IA — podem conter imprecisoes

Síndrome neurológica caracterizada por movimentos desajeitados e descoordenados dos membros, tronco e músculos cranianos. Resulta de patologia no cerebelo e suas conexões, ou nas vias sensoriais proprioceptivas.

Pesquisas ativas
18 ensaios
73 total registrados no ClinicalTrials.gov
Publicações científicas
8 artigos
Último publicado: 2026 Feb
Medicamentos
3 com registro
RILUZOL, ZOLCRIS, LFM-RILUZOL

Tem tratamento?

✓ 3 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
RILUZOLZOLCRISLFM-RILUZOL
Mais 10 moléculas em estudo para esta doença.
🏥
SUS: Cobertura mínimaScore: 0%
CID-10: G11.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
163 sintomas
🦴
Ossos e articulações
83 sintomas
👁️
Olhos
77 sintomas
😀
Face
54 sintomas
💪
Músculos
53 sintomas
🫃
Digestivo
38 sintomas

+ 530 sintomas em outras categorias

Características mais comuns

—
Apatia
—
Telangiectasias mucosas
—
Opérculo aberto
—
Discinesia
—
Anormalidade da abdução ocular
—
Hiperreflexia da mandíbula
1176sintomas
Sem dados (1176)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 1176 características clínicas mais associadas, ordenadas por frequência.

ApatiaApathy
Telangiectasias mucosasMucosal telangiectasiae
Opérculo abertoOpen operculum
DiscinesiaDyskinesia
Anormalidade da abdução ocularAbnormality of ocular abduction

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico8PubMed
Últimos 10 anos2publicações
Pico20251 papers
Linha do tempo
2026Hoje · 2026🧪 2000Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

75 genes identificados com associação a esta condição.

Curadoria gene-doença

fontes oficiais
PRDX3NPTX1
ATG7Ubiquitin-like modifier-activating enzyme ATG7Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
MacroautophagyAntigen processing: Ubiquitination & Proteasome degradationDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 31

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR30 is characterized by global developmental delay, hypotonia, variably impaired intellectual and language development, ataxic gait, tremor, and dysarthria. Most affected individuals have optic atrophy. Additional features may include retinitis pigmentosa, sensorineural deafness, dysmorphic facial features, and possibly endocrine dysfunction.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 31
HGNC:HGNC:16935UniProt:O95352
TWNKTwinkle mtDNA helicaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Strand-asynchronous mitochondrial DNA replicationMitochondrial protein degradationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
21.9 TPM
Testículo
20.3 TPM
Fibroblastos
14.6 TPM
Ovário
10.6 TPM
Útero
10.3 TPM
OUTRAS DOENÇAS (8)
mitochondrial DNA depletion syndrome 7 (hepatocerebral type)Perrault syndrome 5progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3autosomal dominant progressive external ophthalmoplegia
HGNC:1160UniProt:Q96RR1
SPTBN2Spectrin beta chain, non-erythrocytic 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
RAF/MAP kinase cascadeNCAM signaling for neurite out-growthCOPI-mediated anterograde transportInteraction between L1 and AnkyrinsMHC class II antigen presentation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 5

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA5 is an autosomal dominant cerebellar ataxia (ADCA). It is a slowly progressive disorder with variable age at onset, ranging between 10 and 50 years.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
153.6 TPM
Skin Sun Exposed Lower leg
116.8 TPM
Cérebro - Hemisfério cerebelar
113.8 TPM
Testículo
110.1 TPM
Skin Not Sun Exposed Suprapubic
102.0 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 5autosomal recessive spinocerebellar ataxia 14
HGNC:11276UniProt:O15020
MTTPMicrosomal triglyceride transfer protein large subunitCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
VLDL assemblyChylomicron assemblyLDL remodeling
MECANISMO DE DOENÇA

Abetalipoproteinemia

An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
31.1 TPM
Intestino delgado
24.7 TPM
Testículo
7.1 TPM
Ovário
1.8 TPM
Linfócitos
1.2 TPM
OUTRAS DOENÇAS (1)
abetalipoproteinemia
HGNC:7467UniProt:P55157
DAB1Disabled homolog 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Reelin signalling pathway
MECANISMO DE DOENÇA

Spinocerebellar ataxia 37

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA37 is an autosomal dominant form characterized by adult-onset of slowly progressive gait instability, frequent falls, and dysarthria associated with cerebellar atrophy on brain imaging.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
23.7 TPM
Cerebelo
19.4 TPM
Nervo tibial
7.7 TPM
Hipocampo
5.0 TPM
Brain Anterior cingulate cortex BA24
4.7 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 37
HGNC:2661UniProt:O75553
NPTX1Neuronal pentraxin-1Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 50

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA50 is an autosomal dominant form characterized by cerebellar ataxia, oculomotor apraxia and other eye movement abnormalities, and cerebellar atrophy on brain imaging.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
444.5 TPM
Cerebelo
405.9 TPM
Brain Frontal Cortex BA9
112.4 TPM
Córtex cerebral
86.9 TPM
Brain Anterior cingulate cortex BA24
57.5 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia 50
HGNC:HGNC:7952UniProt:Q15818
TDP2Tyrosyl-DNA phosphodiesterase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Nonhomologous End-Joining (NHEJ)
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 23

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Intestino delgado
57.6 TPM
Cérebro - Hemisfério cerebelar
47.5 TPM
Cólon transverso
46.9 TPM
Próstata
44.4 TPM
Linfócitos
41.8 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 23
HGNC:17768UniProt:O95551
TMEM231Transmembrane protein 231Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 20

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
14.2 TPM
Pituitária
13.8 TPM
Fallopian Tube
12.9 TPM
Cervix Endocervix
12.0 TPM
Útero
11.8 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 20Meckel syndrome, type 11Meckel syndromeJoubert syndrome with oculorenal defect
HGNC:37234UniProt:Q9H6L2
SAMD9LSterile alpha motif domain-containing protein 9-likeCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Ataxia-pancytopenia syndrome

An autosomal dominant disorder characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to bone marrow failure and myeloid leukemia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
55.2 TPM
Baço
34.1 TPM
Pulmão
22.9 TPM
Nervo tibial
17.2 TPM
Cervix Endocervix
14.3 TPM
OUTRAS DOENÇAS (4)
monosomy 7 myelodysplasia and leukemia syndrome 1ataxia-pancytopenia syndromespinocerebellar ataxia 49SAMD9L-associated autoinflammatory syndrome
HGNC:1349UniProt:Q8IVG5
SCYL1N-terminal kinase-like proteinCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 21

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR21 is characterized by cerebellar atrophy and ataxia with onset in early childhood. Patients also manifest recurrent episodes of liver failure, hepatic fibrosis and a peripheral neuropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
109.2 TPM
Ovário
108.0 TPM
Cervix Endocervix
107.9 TPM
Cervix Ectocervix
106.3 TPM
Testículo
106.2 TPM
OUTRAS DOENÇAS (1)
acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome
HGNC:14372UniProt:Q96KG9
TBCETubulin-specific chaperone ECandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Post-chaperonin tubulin folding pathway
MECANISMO DE DOENÇA

Hypoparathyroidism-retardation-dysmorphism syndrome

An autosomal recessive multisystem disorder characterized by hypoparathyroidism, intrauterine and postnatal growth retardation, psychomotor retardation, epilepsy, microcephaly, and facial dysmorphism.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
38.8 TPM
Cérebro - Hemisfério cerebelar
35.3 TPM
Fibroblastos
31.5 TPM
Artéria tibial
31.4 TPM
Cerebelo
31.3 TPM
OUTRAS DOENÇAS (4)
autosomal recessive Kenny-Caffey syndromeencephalopathy, progressive, with amyotrophy and optic atrophyhypoparathyroidism-retardation-dysmorphism syndromeearly-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome
HGNC:11582UniProt:Q15813
CAMTA1Calmodulin-binding transcription activator 1Candidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Cerebellar dysfunction with variable cognitive and behavioral abnormalities

An autosomal dominant neurodevelopmental disorder characterized by mildly delayed psychomotor development, early onset of cerebellar ataxia, and intellectual disability later in childhood and adult life. Other features may include neonatal hypotonia, dysarthria, and dysmetria. Brain imaging in some patients shows cerebellar atrophy. Dysmorphic facial features are variable.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
cerebellar dysfunction with variable cognitive and behavioral abnormalitiesepithelioid hemangioendothelioma
HGNC:18806UniProt:Q9Y6Y1
PEX10Peroxisome biogenesis factor 10Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteins
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 7

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.5 TPM
Glândula adrenal
23.3 TPM
Brain Spinal cord cervical c-1
22.1 TPM
Nervo tibial
20.8 TPM
Fibroblastos
20.1 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 6Bperoxisome biogenesis disorder 6A (Zellweger)autosomal recessive ataxia due to PEX10 deficiencyZellweger spectrum disorders
HGNC:8851UniProt:O60683
PDYNProenkephalin-BDisease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsPeptide ligand-binding receptors
MECANISMO DE DOENÇA

Spinocerebellar ataxia 23

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA23 is an adult-onset autosomal dominant form characterized by slowly progressive gait and limb ataxia, with variable additional features, including peripheral neuropathy and dysarthria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
108.5 TPM
Brain Caudate basal ganglia
26.5 TPM
Brain Putamen basal ganglia
11.1 TPM
Testículo
8.9 TPM
Hipotálamo
6.7 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 23
HGNC:8820UniProt:P01213
PNPT1Polyribonucleotide nucleotidyltransferase 1, mitochondrialDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Mitochondrial RNA degradation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 13

A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
39.7 TPM
Fibroblastos
26.0 TPM
Cérebro - Hemisfério cerebelar
21.3 TPM
Brain Spinal cord cervical c-1
20.7 TPM
Testículo
20.4 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 25combined oxidative phosphorylation defect type 13autosomal recessive nonsyndromic hearing loss 70hearing loss, autosomal recessive
HGNC:23166UniProt:Q8TCS8
PITRM1Presequence protease, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 30

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR30 is a progressive disease characterized by childhood-onset global developmental delay with variably impaired intellectual development, motor dysfunction, and cerebellar ataxia. Affected individuals may also have psychiatric abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
58.3 TPM
Aorta
58.3 TPM
Artéria tibial
56.3 TPM
Testículo
52.8 TPM
Útero
50.9 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 30
HGNC:HGNC:17663UniProt:Q5JRX3
GDAP2Ganglioside-induced differentiation-associated protein 2Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 27

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR27 is a progressive disease characterized by gait difficulties, eye movement abnormalities, dysarthria, and difficulty writing. Some patients may lose independent ambulation. Additional features include spasticity of the lower limbs and cognitive impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
5.4 TPM
Cervix Endocervix
4.7 TPM
Pulmão
4.5 TPM
Tireoide
4.4 TPM
Cervix Ectocervix
4.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 27
HGNC:HGNC:18010UniProt:Q9NXN4
PMPCAMitochondrial-processing peptidase subunit alphaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Mitochondrial protein importProcessing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 2

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR2 is characterized by onset of impaired motor development and ataxic gait in early childhood. Additional features often include loss of fine motor skills, dysarthria, nystagmus, cerebellar signs, and delayed cognitive development with intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
65.9 TPM
Testículo
61.0 TPM
Fibroblastos
58.4 TPM
Glândula adrenal
52.2 TPM
Nervo tibial
50.4 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 2
HGNC:18667UniProt:Q10713
FGF14Fibroblast growth factor 14Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Phase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 27A

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA27A is an autosomal dominant, slowly progressive form characterized by gait disturbances, ataxia with tremor, dysarthria, orofacial dyskinesia, gaze-evoked nystagmus, and learning disabilities. There is significant variability, and patients show various combinations of neurologic features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.7 TPM
Cerebelo
16.5 TPM
Brain Frontal Cortex BA9
7.5 TPM
Brain Nucleus accumbens basal ganglia
5.5 TPM
Córtex cerebral
4.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 27Aspinocerebellar ataxia 27B, late-onsetspinocerebellar ataxia type 27
HGNC:3671UniProt:Q92915
VLDLRVery low-density lipoprotein receptorCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
VLDL clearanceVLDLR internalisation and degradationReelin signalling pathway
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1

An autosomal recessive, congenital, non-progressive cerebellar ataxia associated with disturbed equilibrium, delayed ambulation, intellectual disability, cerebellar hypoplasia and mild cerebral gyral simplification. Additional features include short stature, strabismus, pes planus and, rarely, seizures.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
81.6 TPM
Artéria tibial
18.7 TPM
Coração - Átrio
18.7 TPM
Coração - Ventrículo esquerdo
16.5 TPM
Fallopian Tube
15.2 TPM
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:12698UniProt:P98155
CTDP1RNA polymerase II subunit A C-terminal domain phosphataseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (10)
TP53 Regulates Transcription of DNA Repair GenesFormation of HIV elongation complex in the absence of HIV TatFormation of the HIV-1 Early Elongation ComplexAbortive elongation of HIV-1 transcript in the absence of TatFormation of HIV-1 elongation complex containing HIV-1 Tat
MECANISMO DE DOENÇA

Congenital cataracts, facial dysmorphism, and neuropathy

An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
34.3 TPM
Skin Sun Exposed Lower leg
22.0 TPM
Skin Not Sun Exposed Suprapubic
18.4 TPM
Sangue
17.1 TPM
Baço
16.3 TPM
OUTRAS DOENÇAS (1)
congenital cataracts-facial dysmorphism-neuropathy syndrome
HGNC:2498UniProt:Q9Y5B0
WWOXWW domain-containing oxidoreductaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
MKS1Tectonic-like complex member MKS1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 1

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.3 TPM
Ovário
22.3 TPM
Útero
20.0 TPM
Cervix Endocervix
18.8 TPM
Pituitária
18.7 TPM
OUTRAS DOENÇAS (7)
Joubert syndrome 28Bardet-Biedl syndrome 13Meckel syndrome, type 1Joubert syndrome
HGNC:7121UniProt:Q9NXB0
FMR1Fragile X messenger ribonucleoprotein 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
FCGR3A-mediated phagocytosisRHO GTPases Activate WASPs and WAVEsRegulation of actin dynamics for phagocytic cup formationVEGFA-VEGFR2 PathwayRAC1 GTPase cycle
MECANISMO DE DOENÇA

Fragile X syndrome

An X-linked dominant disease characterized by moderate to severe intellectual disability, macroorchidism (enlargement of the testicles), large ears, prominent jaw, and high-pitched, jocular speech. The defect in most patients results from an amplification of a CGG repeat region in the FMR1 gene and abnormal methylation.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.4 TPM
Ovário
32.4 TPM
Tireoide
31.7 TPM
Nervo tibial
30.4 TPM
Cerebelo
29.7 TPM
OUTRAS DOENÇAS (4)
premature ovarian failure 1fragile X syndromefragile X-associated tremor/ataxia syndromeXq27.3q28 duplication syndrome
HGNC:3775UniProt:Q06787
TMEM216Transmembrane protein 216Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 2

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
31.3 TPM
Pituitária
27.0 TPM
Cervix Endocervix
25.9 TPM
Cervix Ectocervix
24.7 TPM
Testículo
23.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 98Meckel syndrome, type 2Joubert syndrome 2Meckel syndrome
HGNC:25018UniProt:Q9P0N5
SETXHelicase senataxinDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN2 is an autosomal recessive form associated with peripheral neuropathy and elevated serum alpha-fetoprotein, immunoglobulins and, less commonly, creatine kinase levels. Some SCAN2 patients manifest oculomotor apraxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
50.4 TPM
Linfócitos
39.4 TPM
Tireoide
36.1 TPM
Baço
32.8 TPM
Pulmão
25.9 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2amyotrophic lateral sclerosis type 4
HGNC:445UniProt:Q7Z333
CCDC88CProtein DapleCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by DVL-interacting proteins
MECANISMO DE DOENÇA

Hydrocephalus, congenital, 1

A form of congenital hydrocephalus, a disease characterized by onset in utero of enlarged ventricles due to accumulation of ventricular cerebrospinal fluid. Affected individuals may have neurologic impairment. HYC1 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
hydrocephalus, nonsyndromic, autosomal recessive 1spinocerebellar ataxia type 40congenital non-communicating hydrocephalus
HGNC:19967UniProt:Q9P219
CEP41Centrosomal protein of 41 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 15

An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly.

OUTRAS DOENÇAS (3)
Joubert syndrome 15Joubert syndromeJoubert syndrome with ocular defect
HGNC:12370UniProt:Q9BYV8
ANO10Anoctamin-10Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 10

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR10 is characterized by onset in the teenage or young adult years of gait and limb ataxia, dysarthria, and nystagmus associated with marked cerebellar atrophy on brain imaging.

OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 10
HGNC:25519UniProt:Q9NW15
EEF2Elongation factor 2Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 26

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
2998.1 TPM
Fibroblastos
2856.0 TPM
Linfócitos
2101.6 TPM
Cervix Endocervix
1850.1 TPM
Útero
1835.9 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 26
HGNC:3214UniProt:P13639
COA7Cytochrome c oxidase assembly factor 7Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN3 is an autosomal recessive disorder characterized by onset in the first decade of slowly progressive distal muscle weakness and atrophy and distal sensory impairment due to an axonal peripheral neuropathy. Affected individuals have gait disturbances and sometimes manual dexterity difficulties, as well as cerebellar ataxia associated with cerebellar atrophy on brain imaging.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
HGNC:HGNC:25716UniProt:Q96BR5
STUB1E3 ubiquitin-protein ligase CHIPDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (8)
Downregulation of TGF-beta receptor signalingAntigen processing: Ubiquitination & Proteasome degradationRIPK1-mediated regulated necrosisRegulation of necroptotic cell deathRegulation of TNFR1 signaling
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 16

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR16 is characterized by truncal and limb ataxia resulting in gait instability. Additionally, patients may show dysarthria, nystagmus, spasticity of the lower limbs, and mild peripheral sensory neuropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
136.1 TPM
Cerebelo
123.5 TPM
Brain Frontal Cortex BA9
121.3 TPM
Artéria tibial
109.3 TPM
Skin Sun Exposed Lower leg
108.7 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia 48autosomal recessive spinocerebellar ataxia 16
HGNC:11427UniProt:Q9UNE7
KCNC3Voltage-gated potassium channel KCNC3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 13

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA13 is an autosomal dominant cerebellar ataxia (ADCA) characterized by slow progression and variable age at onset, ranging from childhood to late adulthood. Intellectual disability can be present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
78.2 TPM
Tireoide
63.5 TPM
Cérebro - Hemisfério cerebelar
61.8 TPM
Pituitária
24.0 TPM
Brain Frontal Cortex BA9
22.1 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 13
HGNC:6235UniProt:Q14003
GRM1Metabotropic glutamate receptor 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
G alpha (q) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)Neurexins and neuroligins
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 13

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR13 is characterized by delayed psychomotor development beginning in infancy. Affected individuals show mild to profound intellectual disability with poor or absent speech as well as gait and stance ataxia and hyperreflexia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
38.4 TPM
Cerebelo
30.6 TPM
Brain Frontal Cortex BA9
5.7 TPM
Córtex cerebral
3.6 TPM
Brain Anterior cingulate cortex BA24
3.6 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 44autosomal recessive spinocerebellar ataxia 13chondromyxoid fibroma
HGNC:4593UniProt:Q13255
PEX6Peroxisomal ATPase PEX6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 4

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
66.8 TPM
Ovário
64.6 TPM
Cerebelo
61.1 TPM
Cérebro - Hemisfério cerebelar
58.5 TPM
Pituitária
55.1 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 4Bperoxisome biogenesis disorder 4A (Zellweger)peroxisome biogenesis disorder due to PEX6 defectobsolete Heimler syndrome
HGNC:8859UniProt:Q13608
PLEKHG4Puratrophin-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
RAC1 GTPase cycleCDC42 GTPase cycleRHOA GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
78.0 TPM
Ovário
30.6 TPM
Fibroblastos
23.8 TPM
Nervo tibial
17.9 TPM
Mama
14.2 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 4
HGNC:24501UniProt:Q58EX7
TPP1Tripeptidyl-peptidase 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
XBP1(S) activates chaperone genes
MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 2

A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment pattern seen most often in CLN2 consists of curvilinear profiles.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
192.2 TPM
Glândula adrenal
173.0 TPM
Fibroblastos
138.0 TPM
Pulmão
131.9 TPM
Útero
116.5 TPM
OUTRAS DOENÇAS (2)
autosomal recessive spinocerebellar ataxia 7neuronal ceroid lipofuscinosis 2
HGNC:2073UniProt:O14773
DNMT1DNA (cytosine-5)-methyltransferase 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
STAT3 nuclear events downstream of ALK signalingNuclear events stimulated by ALK signaling in cancerDefective pyroptosisPRC2 methylates histones and DNADNA methylation
MECANISMO DE DOENÇA

Neuropathy, hereditary sensory, 1E

A neurodegenerative disorder characterized by adult onset of progressive peripheral sensory loss associated with progressive hearing impairment and early-onset dementia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
84.0 TPM
Testículo
56.6 TPM
Cérebro - Hemisfério cerebelar
54.8 TPM
Cerebelo
53.6 TPM
Fibroblastos
46.5 TPM
OUTRAS DOENÇAS (2)
autosomal dominant cerebellar ataxia, deafness and narcolepsyhereditary sensory neuropathy-deafness-dementia syndrome
HGNC:2976UniProt:P26358
TMEM237Transmembrane protein 237Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 14

An autosomal recessive disorder characterized by severe intellectual disability, hypotonia, breathing abnormalities in infancy, and dysmorphic facial features. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include renal disease, abnormal eye movements, and postaxial polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
30.8 TPM
Skin Not Sun Exposed Suprapubic
24.6 TPM
Skin Sun Exposed Lower leg
22.7 TPM
Artéria tibial
20.4 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 14Meckel syndromeJoubert syndrome with oculorenal defectJoubert syndrome
HGNC:14432UniProt:Q96Q45
POU4F1POU domain, class 4, transcription factor 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of TP53 Activity through Association with Co-factors
MECANISMO DE DOENÇA

Ataxia, intention tremor, and hypotonia syndrome, childhood-onset

An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, mildly impaired intellectual development with speech delay or learning disabilities, delayed walking due to ataxia, intention tremor, and hypotonia apparent from early childhood. Brain imaging shows cerebellar atrophy in some patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.1 TPM
Linfócitos
0.4 TPM
Brain Spinal cord cervical c-1
0.4 TPM
Skin Sun Exposed Lower leg
0.1 TPM
Skin Not Sun Exposed Suprapubic
0.1 TPM
OUTRAS DOENÇAS (2)
ataxia, intention tremor, and hypotonia syndrome, childhood-onsetcerebellar dysfunction with variable cognitive and behavioral abnormalities
HGNC:9218UniProt:Q01851
CACNA1GVoltage-dependent T-type calcium channel subunit alpha-1GDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
NCAM1 interactionsSmooth Muscle Contraction
MECANISMO DE DOENÇA

Spinocerebellar ataxia 42

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA42 is a slowly progressive, autosomal dominant form with variable severity.

OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 42spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
HGNC:1394UniProt:O43497
RNF168E3 ubiquitin-protein ligase RNF168Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksG2/M DNA damage checkpointProcessing of DNA double-strand break endsNonhomologous End-Joining (NHEJ)SUMOylation of DNA damage response and repair proteins
MECANISMO DE DOENÇA

Riddle syndrome

An autosomal recessive disorder characterized by increased radiosensitivity, immunodeficiency, mild motor control and learning difficulties, facial dysmorphism, and short stature.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
45.1 TPM
Linfócitos
29.6 TPM
Skin Sun Exposed Lower leg
20.0 TPM
Cervix Ectocervix
19.6 TPM
Skin Not Sun Exposed Suprapubic
18.6 TPM
OUTRAS DOENÇAS (1)
RIDDLE syndrome
HGNC:26661UniProt:Q8IYW5
KIAA0586Protein TALPID3Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 23

A mild form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
16.6 TPM
Linfócitos
8.7 TPM
Cérebro - Hemisfério cerebelar
7.1 TPM
Cerebelo
6.7 TPM
Fibroblastos
6.4 TPM
OUTRAS DOENÇAS (4)
Joubert syndrome 23short-rib thoracic dysplasia 14 with polydactylyJoubert syndromeJoubert syndrome with Jeune asphyxiating thoracic dystrophy
HGNC:19960UniProt:Q9BVV6
PUM1Pumilio homolog 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism

An autosomal dominant disorder characterized by global developmental delay, impaired intellectual development, early-onset seizures, poor overall growth, delayed walking, hypotonia and/or ataxia, and facial dysmorphism. Some patients have hypoplasia of the corpus callosum and cerebral atrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
56.0 TPM
Ovário
54.0 TPM
Nervo tibial
52.9 TPM
Artéria tibial
52.6 TPM
Cérebro - Hemisfério cerebelar
51.0 TPM
OUTRAS DOENÇAS (2)
neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphismspinocerebellar ataxia 47
HGNC:14957UniProt:Q14671
PNKPBifunctional polynucleotide phosphatase/kinaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
MECANISMO DE DOENÇA

Microcephaly, seizures, and developmental delay

An autosomal recessive neurodevelopmental disorder characterized by infantile-onset seizures, microcephaly, severe intellectual disability and delayed motor milestones with absent speech or only achieving a few words. Most patients also have behavioral problems with hyperactivity. Microcephaly is progressive and without neuronal migration or structural abnormalities, consistent with primary microcephaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
66.8 TPM
Tireoide
63.9 TPM
Baço
59.2 TPM
Glândula adrenal
55.9 TPM
Cervix Endocervix
51.8 TPM
OUTRAS DOENÇAS (4)
microcephaly, seizures, and developmental delayataxia - oculomotor apraxia type 4Charcot-Marie-Tooth disease type 2B2early-infantile DEE
HGNC:9154UniProt:Q96T60
GRID2Glutamate receptor ionotropic, delta-2Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 18

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR18 features include progressive cerebellar atrophy, delayed psychomotor development, severely impaired gait, ocular movement abnormalities, and intellectual disability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
10.4 TPM
Cérebro - Hemisfério cerebelar
7.5 TPM
Testículo
6.2 TPM
Brain Nucleus accumbens basal ganglia
1.8 TPM
Hipotálamo
1.6 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 18
HGNC:4576UniProt:O43424
BEAN1Protein BEAN1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia 31

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA31 belongs to the autosomal dominant cerebellar ataxias type III (ADCA III) which are characterized by pure cerebellar ataxia without additional signs.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 31
HGNC:24160UniProt:Q3B7T3
ATXN2Ataxin-2Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 2

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is characterized by hyporeflexia, myoclonus and action tremor and dopamine-responsive parkinsonism. In some patients, SCA2 presents as pure familial parkinsonism without cerebellar signs.

OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 2amyotrophic lateral sclerosislate-onset Parkinson disease
HGNC:10555UniProt:Q99700
AHI1JouberinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 3

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 3 shows minimal extra central nervous system involvement and appears not to be associated with renal dysfunction.

OUTRAS DOENÇAS (4)
Joubert syndrome 3Joubert syndromeretinitis pigmentosaJoubert syndrome with ocular defect
HGNC:21575UniProt:Q8N157
RUBCNRun domain Beclin-1-interacting and cysteine-rich domain-containing proteinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 15

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR15 patients manifest cerebellar ataxia in early childhood and delayed motor development with delayed walking. Additional features include dysarthria, upper limb involvement, abnormal eye movements, and hyporeflexia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
38.4 TPM
Cérebro - Hemisfério cerebelar
34.0 TPM
Cerebelo
30.9 TPM
Testículo
27.1 TPM
Baço
26.4 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 15
HGNC:28991UniProt:Q92622
GJB1Gap junction beta-1 proteinCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
Oligomerization of connexins into connexonsGap junction assemblyTransport of connexins along the secretory pathway
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, X-linked dominant, 1

A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies characterized by severely reduced motor nerve conduction velocities (NCVs) (less than 38m/s) and segmental demyelination and remyelination, and primary peripheral axonal neuropathies characterized by normal or mildly reduced NCVs and chronic axonal degeneration and regeneration on nerve biopsy. CMTX1 has both demyelinating and axonal features. Central nervous system involvement may occur.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
187.2 TPM
Brain Spinal cord cervical c-1
172.2 TPM
Pâncreas
56.1 TPM
Substância negra
44.4 TPM
Cólon transverso
27.3 TPM
OUTRAS DOENÇAS (2)
Charcot-Marie-Tooth disease X-linked dominant 1X-linked progressive cerebellar ataxia
HGNC:4283UniProt:P08034
ATN1Atrophin-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of PTEN gene transcription
MECANISMO DE DOENÇA

Dentatorubral-pallidoluysian atrophy

Autosomal dominant neurodegenerative disorder characterized by a loss of neurons in the dentate nucleus, rubrum, glogus pallidus and Luys'body. Clinical features are myoclonus epilepsy, dementia, and cerebellar ataxia. Onset of the disease occurs usually in the second decade of life and death in the fourth.

OUTRAS DOENÇAS (2)
dentatorubral-pallidoluysian atrophycongenital hypotonia, epilepsy, developmental delay, and digital anomalies
HGNC:3033UniProt:P54259
ATXN3Ataxin-3Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genesJosephin domain DUBs
MECANISMO DE DOENÇA

Spinocerebellar ataxia 3

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATX3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

OUTRAS DOENÇAS (5)
Machado-Joseph diseaseMachado-Joseph disease type 3Machado-Joseph disease type 2Machado-Joseph disease type 1
HGNC:7106UniProt:P54252
PPP2R2BSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoformDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 12

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA12 is an autosomal dominant cerebellar ataxia (ADCA).

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
29.9 TPM
Brain Nucleus accumbens basal ganglia
24.8 TPM
Córtex cerebral
24.7 TPM
Brain Caudate basal ganglia
22.5 TPM
Brain Anterior cingulate cortex BA24
20.2 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 12
HGNC:9305UniProt:Q00005
TMEM138Transmembrane protein 138Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 16

An autosomal recessive disorder characterized by oculomotor apraxia, variable coloboma, and rare kidney involvement. Neuroradiologically, it is characterized by an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
46.1 TPM
Ovário
37.6 TPM
Fallopian Tube
34.8 TPM
Útero
32.5 TPM
Cervix Endocervix
31.2 TPM
OUTRAS DOENÇAS (2)
Joubert syndrome 16Joubert syndrome with oculorenal defect
HGNC:26944UniProt:Q9NPI0
RNU12Candidate gene tested inDesconhecido
VIAS BIOLÓGICAS (1)
RNA polymerase II transcribes snRNA genes
OUTRAS DOENÇAS (3)
craniosynostosis-anal anomalies-porokeratosis syndromespinocerebellar ataxia, autosomal recessive 33congenital cerebellar ataxia due to RNU12 mutation
HGNC:19380
ATP8A2Phospholipid-transporting ATPase IBCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4

An autosomal recessive, congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and intellectual disability.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:13533UniProt:Q9NTI2
SLC9A1Sodium/hydrogen exchanger 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Hyaluronan degradationSodium/Proton exchangers
MECANISMO DE DOENÇA

Lichtenstein-Knorr syndrome

An autosomal recessive neurologic disorder characterized by progressive cerebellar ataxia and severe progressive sensorineural hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
33.1 TPM
Glândula salivar
30.3 TPM
Cólon transverso
29.6 TPM
Pulmão
29.2 TPM
Cervix Ectocervix
28.0 TPM
OUTRAS DOENÇAS (1)
Lichtenstein-Knorr syndrome
HGNC:11071UniProt:P19634
SNX14Sorting nexin-14Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 20

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR20 is characterized by cerebellar atrophy, ataxia, coarsened facial features, severely delayed psychomotor development with poor or absent speech, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
58.2 TPM
Fibroblastos
33.8 TPM
Tireoide
33.7 TPM
Cérebro - Hemisfério cerebelar
32.0 TPM
Linfócitos
31.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 20
HGNC:14977UniProt:Q9Y5W7
CSPP1Centrosome and spindle pole-associated protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 21

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.0 TPM
Cérebro - Hemisfério cerebelar
10.9 TPM
Fallopian Tube
9.5 TPM
Cervix Endocervix
9.5 TPM
Ovário
9.4 TPM
OUTRAS DOENÇAS (4)
Joubert syndrome 21Joubert syndromeJoubert syndrome with Jeune asphyxiating thoracic dystrophyMeckel syndrome
HGNC:26193UniProt:Q1MSJ5
CA8Carbonic anhydrase-related proteinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 34

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR34 is characterized by congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and intellectual disability.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:1382UniProt:P35219
AFG3L2Mitochondrial inner membrane m-AAA protease component AFG3L2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Processing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 28

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA28 is an autosomal dominant cerebellar ataxia (ADCA) with a slow progressive course and no evidence of sensory involvement or cognitive impairment.

OUTRAS DOENÇAS (3)
optic atrophy 12spinocerebellar ataxia type 28spastic ataxia 5
HGNC:315UniProt:Q9Y4W6
ITPR1Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Ion homeostasisRegulation of insulin secretionFCGR3A-mediated IL10 synthesisAntigen activates B Cell Receptor (BCR) leading to generation of second messengersCLEC7A (Dectin-1) induces NFAT activation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 15

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
82.0 TPM
Cerebelo
76.2 TPM
Artéria coronária
59.8 TPM
Aorta
52.7 TPM
Fallopian Tube
47.8 TPM
OUTRAS DOENÇAS (3)
aniridia-cerebellar ataxia-intellectual disability syndromespinocerebellar ataxia type 29spinocerebellar ataxia type 15/16
HGNC:6180UniProt:Q14643
THG1LProbable tRNA(His) guanylyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 28

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR28 patients manifest mild motor developmental delay, gait ataxia, and dysarthria. Some patients show mildly impaired intellectual development. Disease onset is in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
20.2 TPM
Fibroblastos
17.3 TPM
Bladder
15.8 TPM
Útero
15.3 TPM
Cervix Ectocervix
15.1 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 28
HGNC:HGNC:26053UniProt:Q9NWX6
ATXN1Ataxin-1Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 1

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 1
HGNC:10548UniProt:P54253
RPGRIP1LProtein fantomCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.1 TPM
Fibroblastos
7.3 TPM
Pituitária
5.6 TPM
Ovário
3.0 TPM
Cervix Endocervix
3.0 TPM
OUTRAS DOENÇAS (6)
Meckel syndrome, type 5Joubert syndrome 7COACH syndrome 3COACH syndrome
HGNC:29168UniProt:Q68CZ1
ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637
FXNFrataxin, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Friedreich ataxia

Autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
12.5 TPM
Linfócitos
11.2 TPM
Glândula adrenal
10.8 TPM
Fibroblastos
10.6 TPM
Útero
9.3 TPM
OUTRAS DOENÇAS (2)
Friedreich ataxia 1Friedreich ataxia
HGNC:3951UniProt:Q16595
TMEM240Transmembrane protein 240Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Spinocerebellar ataxia 21

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA21 is characterized by onset in the first decades of life of slowly progressive relatively mild cerebellar ataxia associated with slight extrapyramidal features predominant in older patients and cognitive impairment predominant in younger patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
59.7 TPM
Cerebelo
57.9 TPM
Brain Frontal Cortex BA9
28.4 TPM
Córtex cerebral
26.7 TPM
Brain Nucleus accumbens basal ganglia
22.9 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 21
HGNC:25186UniProt:Q5SV17
SIL1Nucleotide exchange factor SIL1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Marinesco-Sjoegren syndrome

Autosomal recessive multisystem disorder which is characterized by cerebellar ataxia due to cerebellar atrophy, with Purkinje and granule cell loss and myopathy featuring marked muscle replacement with fat and connective tissue. Other cardinal features include bilateral cataracts, hypergonadotrophic hypogonadism and mild to severe intellectual disability. Skeletal abnormalities, short stature, dysarthria, strabismus and nystagmus are also frequent findings. Mutational inactivation of this protein may result in ER stress-induced cell death signaling or malfunctioning chaperone machineries that mishandle client proteins which are critical for the organs targeted in MSS.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
59.1 TPM
Fibroblastos
41.1 TPM
Glândula adrenal
36.4 TPM
Tireoide
32.5 TPM
Pituitária
31.3 TPM
OUTRAS DOENÇAS (1)
Marinesco-Sjogren syndrome
HGNC:24624UniProt:Q9H173
CC2D2ACoiled-coil and C2 domain-containing protein 2ACandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 6

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

OUTRAS DOENÇAS (8)
retinitis pigmentosa 93COACH syndrome 2Joubert syndrome 9Meckel syndrome, type 6
HGNC:29253UniProt:Q9P2K1
TUBB2BTubulin beta-2B chainCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Cortical dysplasia, complex, with other brain malformations 7

A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
377.8 TPM
Brain Nucleus accumbens basal ganglia
248.1 TPM
Substância negra
229.1 TPM
Hipotálamo
205.3 TPM
Brain Caudate basal ganglia
203.2 TPM
OUTRAS DOENÇAS (4)
complex cortical dysplasia with other brain malformations 7tubulinopathy-associated dysgyriacerebellar ataxia, intellectual disability, and dysequilibriumcongenital fibrosis of extraocular muscles
HGNC:30829UniProt:Q9BVA1
KCND3A-type voltage-gated potassium channel KCND3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Phase 1 - inactivation of fast Na+ channelsVoltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 19

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA19 is a relatively mild, cerebellar ataxic syndrome with cognitive impairment, pyramidal tract involvement, tremor and peripheral neuropathy, and mild atrophy of the cerebellar hemispheres and vermis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
62.6 TPM
Cerebelo
56.0 TPM
Brain Frontal Cortex BA9
23.7 TPM
Córtex cerebral
19.4 TPM
Esôfago - Muscular
16.0 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 19/22Brugada syndrome 9Brugada syndrome
HGNC:6239UniProt:Q9UK17
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
ELOVL4Very long chain fatty acid elongase 4Disease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (1)
Synthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Stargardt disease 3

A form of Stargardt disease, a common hereditary macular degeneration characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD3 is an autosomal dominant form with onset most commonly in the second decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
68.2 TPM
Skin Not Sun Exposed Suprapubic
64.1 TPM
Cérebro - Hemisfério cerebelar
43.9 TPM
Cerebelo
27.9 TPM
Brain Frontal Cortex BA9
23.3 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 34Stargardt disease 3congenital ichthyosis-intellectual disability-spastic quadriplegia syndromeStargardt disease
HGNC:14415UniProt:Q9GZR5

Medicamentos e terapias

CHENODIOLPhase 4

Mecanismo: Bile acid receptor FXR agonist

OMAVELOXOLONEPhase 4

Mecanismo: Nuclear factor erythroid 2-related factor 2 activator

ROVATIRELINPhase 3

Mecanismo: Thyrotropin-releasing hormone receptor agonist

RILUZOLEPhase 3

Mecanismo: Sodium channel alpha subunit blocker

DEXAMETHASONE PHOSPHORIC ACIDPhase 3

Mecanismo: Glucocorticoid receptor agonist

DEXAMETHASONE SODIUM PHOSPHATEPhase 3

Mecanismo: Glucocorticoid receptor agonist

VATIQUINONEPhase 3

Mecanismo: Quinone reductase 1 modulator

PIOGLITAZONEPhase 3

Mecanismo: Peroxisome proliferator-activated receptor gamma agonist

INTERFERON GAMMA-1BPhase 3

Mecanismo: Interferon gamma receptor agonist

NILOTINIBPhase 2

Mecanismo: Tyrosine-protein kinase ABL inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

515 variantes patogênicas registradas no ClinVar.

🧬 ATG7: GRCh37/hg19 3p26.3-14.3(chr3:2263690-55016039)x3 ()
🧬 ATG7: NM_001128219.3(VGLL4):c.620-3C>T ()
🧬 ATG7: NM_001349232.2(ATG7):c.2080-45G>A ()
🧬 ATG7: NM_001349232.2(ATG7):c.1799+12A>G ()
🧬 ATG7: NM_001349232.2(ATG7):c.1480-2A>T ()
Ver todas no ClinVar

Vias biológicas (Reactome)

159 vias biológicas associadas aos genes desta condição.

Macroautophagy Neutrophil degranulation Signaling by BRAF and RAF1 fusions Antigen processing: Ubiquitination & Proteasome degradation Dengue Virus Attachment and Entry Transcriptional activation of mitochondrial biogenesis Mitochondrial protein degradation Strand-asynchronous mitochondrial DNA replication MHC class II antigen presentation NCAM signaling for neurite out-growth Interaction between L1 and Ankyrins RAF/MAP kinase cascade COPI-mediated anterograde transport VLDL assembly Chylomicron assembly LDL remodeling Reelin signalling pathway Nonhomologous End-Joining (NHEJ) Post-chaperonin tubulin folding pathway E3 ubiquitin ligases ubiquitinate target proteins Peroxisomal protein import Opioid Signalling G-protein activation Peptide ligand-binding receptors G alpha (i) signalling events Mitochondrial RNA degradation Mitochondrial protein import Processing of SMDT1 Phase 0 - rapid depolarisation VLDLR internalisation and degradation VLDL clearance Formation of RNA Pol II elongation complex Formation of the Early Elongation Complex Formation of HIV elongation complex in the absence of HIV Tat Formation of the HIV-1 Early Elongation Complex Formation of HIV-1 elongation complex containing HIV-1 Tat Pausing and recovery of Tat-mediated HIV elongation Abortive elongation of HIV-1 transcript in the absence of Tat Tat-mediated HIV elongation arrest and recovery Tat-mediated elongation of the HIV-1 transcript HIV elongation arrest and recovery Pausing and recovery of HIV elongation RNA Polymerase II Pre-transcription Events TP53 Regulates Transcription of DNA Repair Genes RNA Polymerase II Transcription Elongation Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors Hedgehog 'off' state Anchoring of the basal body to the plasma membrane CYFIP2 CYFIP1 CYFIP1 CYFIP1 CYFIP1 CYFIP1 Negative regulation of TCF-dependent signaling by DVL-interacting proteins Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes AURKA Activation by TPX2 Stimuli-sensing channels Induction of Cell-Cell Fusion Peptide chain elongation Uptake and function of diphtheria toxin Synthesis of diphthamide-EEF2 Protein methylation Downregulation of TGF-beta receptor signaling RIPK1-mediated regulated necrosis Regulation of TNFR1 signaling Regulation of necroptotic cell death Downregulation of ERBB2 signaling Regulation of RUNX2 expression and activity Regulation of PTEN stability and activity Voltage gated Potassium channels G alpha (q) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) Neurexins and neuroligins Sensory perception of sweet, bitter, and umami (glutamate) taste RHOA GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle XBP1(S) activates chaperone genes PRC2 methylates histones and DNA NoRC negatively regulates rRNA expression SUMOylation of DNA methylation proteins DNA methylation STAT3 nuclear events downstream of ALK signaling Defective pyroptosis Nuclear events stimulated by ALK signaling in cancer Regulation of TP53 Activity through Association with Co-factors NCAM1 interactions Smooth Muscle Contraction SUMOylation of DNA damage response and repair proteins Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Processing of DNA double-strand break ends G2/M DNA damage checkpoint Golgi Associated Vesicle Biogenesis APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway Oligomerization of connexins into connexons Transport of connexins along the secretory pathway Gap junction assembly Regulation of PTEN gene transcription Josephin domain DUBs FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes RNU12 gene U12 snRNA U1,U2,U4,U4atac,U5,U11,U12 gene Ion transport by P-type ATPases Hyaluronan degradation Sodium/Proton exchangers PLC beta mediated events Effects of PIP2 hydrolysis Elevation of cytosolic Ca2+ levels DAG and IP3 signaling Role of phospholipids in phagocytosis FCERI mediated Ca+2 mobilization Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Ca2+ pathway cGMP effects Regulation of insulin secretion VEGFR2 mediated cell proliferation Ion homeostasis CLEC7A (Dectin-1) induces NFAT activation FCGR3A-mediated IL10 synthesis Antigen activates B Cell Receptor (BCR) leading to generation of second messengers tRNA modification in the nucleus and cytosol Potential therapeutics for SARS Mitochondrial iron-sulfur cluster biogenesis Maturation of TCA enzymes and regulation of TCA cycle Complex III assembly Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Recycling pathway of L1 Cargo trafficking to the periciliary membrane Intraflagellar transport RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-dependent Golgi-to-ER retrograde traffic COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint Carboxyterminal post-translational modifications of tubulin HCMV Early Events Assembly and cell surface presentation of NMDA receptors Activation of AMPK downstream of NMDARs Aggrephagy EML4 and NUDC in mitotic spindle formation Sealing of the nuclear envelope (NE) by ESCRT-III Kinesins Phase 1 - inactivation of fast Na+ channels Synthesis of very long-chain fatty acyl-CoAs

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado2
3Fase 39
2Fase 29
1Fase 12
·Pré-clínico61
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 73 ensaios
✓ Aprovados — podem ser usados hoje
CHENODIOLOMAVELOXOLONE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ataxia rara

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 12 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

10 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

73 ensaios clínicos encontrados, 18 ativos.

Distribuição por fase
NCT07211490 · rTMS for Cerebellar Ataxia in ChildrenEm breve
NA🇨🇳 China
NCT07079332 · Structural Validity and Inter-rater Reliabitiliy of the Atax…Em breve
NCT06089863 · Rehabilitation Program on Genetic and Degenerative AtaxiaEm breve
NA🇫🇷 França
NCT06573866 · Enhancement of Quality of Work And LifeAtivo
NA🇳🇱 Países Baixos
NCT07250321 · Efficacy of tDCS in Degenerative AtaxiaAtivo
NA🇮🇹 Itália
NCT05351255 · Motor Learning After Cerebellar Damage: The Role of the Prim…Ativo
NA🇺🇸 Estados Unidos
NCT03972202 · The Role of Cerebellum in SpeechAtivo
NA🇺🇸 Estados Unidos
NCT04529252 · Investigating the Genetic and Phenotypic Presentation of Ata…Ativo
🇺🇸 Estados Unidos
NCT07352085 · Exoskeleton-assisted NeurorehabilitationConcluído
NAHungary
NCT06450457 · Effects of High Intensity Stepping Training on Gait in Patie…Concluído
NA🇺🇸 Estados Unidos
NCT06152133 · Telerehabilitation, Core Stability Exercises and Hereditary …Concluído
NA🇪🇸 Espanha
NCT05436262 · Using Real-time fMRI Neurofeedback and Motor Imagery to Enha…Concluído
NA🇺🇸 Estados Unidos
NCT05992207 · Utilization of Motor Imagery Training for Improvement of Bal…Concluído
NA🇪🇬 Egito
NCT05436249 · Use of Real-Time Functional Magnetic Resonance Imaging Neuro…Concluído
NA🇺🇸 Estados Unidos
NCT05278091 · Evaluation of the Diagnostic Value of Video-oculography in C…Concluído
🇫🇷 França
NCT05002218 · Training in Ataxia - Individuals With Degenerative Cerebella…Concluído
NA🇺🇸 Estados Unidos
NCT04703595 · Chronic Cough and CANVAS (Cerebellar Ataxia With Neuropathy …Concluído
🇪🇸 Espanha
NCT05095870 · Evaluation of the Peripheral Nerve Ultrasound as a Diagnosti…Concluído
🇫🇷 França
NCT04937725 · Reading Problems Associated With Central Nervous System (CNS…Concluído
🇪🇸 Espanha
NCT04750850 · Core Stability Exercises and Hereditary AtaxiaConcluído
NA🇪🇸 Espanha
NCT05471310 · Videoocular Assessment of Eye Movement Activity in an Ataxia…Concluído
Russia
NCT04648501 · Dual Task Training for Cerebellar AtaxiaConcluído
NAHong Kong
NCT05621200 · Transcranial Alternating Current Stimulation (tACS) in Patie…Concluído
NA🇮🇹 Itália
NCT04790981 · Effect of Motor Imagery Training on Ataxic Children After Me…Concluído
NA🇪🇬 Egito
NCT04099914 · Validation of a Clinical Algorithm for the Diagnosis of Rece…Concluído
🇫🇷 França
NCT04153110 · Cerebello-Spinal tDCS as Rehabilitative Intervention in Neur…Concluído
NA🇮🇹 Itália
NCT03932669 · Effect of Nilotinib in Cerebellar Ataxia PatientsConcluído
PHASE2South Korea
NCT03120013 · Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodege…Concluído
NA🇮🇹 Itália
NCT02903290 · Longitudinal Monitoring of Energy Expenditure, Dynamic Stabi…Concluído
NA🇫🇷 França
NCT02887703 · Augmenting Balance in Individuals With Cerebellar AtaxiasConcluído
NA🇺🇸 Estados Unidos
NCT02488031 · Functional and Structural Imaging and Motor Control in Spino…Concluído
NA🇺🇸 Estados Unidos
NCT02540655 · Efficacy and Safety Study of Stemchymal® in Polyglutamine Sp…Concluído
PHASE2🇹🇼 Taiwan
NCT02900508 · Virtual Reality-based Training in Cerebellar AtaxiaConcluído
NA
NCT02106819 · Emotional Communication Disorders in Cerebellar DiseaseConcluído
🇺🇸 Estados Unidos
NCT01649687 · Treatment of Cerebellar Ataxia With Mesenchymal Stem CellsConcluído
PHASE1, PHASE2🇹🇼 Taiwan
NCT01307176 · Exercise Training Program for Cerebellar AtaxiaConcluído
NA🇺🇸 Estados Unidos
NCT01104649 · Efficacy of Riluzole in Hereditary Cerebellar AtaxiaConcluído
PHASE2, PHASE3🇮🇹 Itália
NCT00202397 · Effect of Riluzole as a Symptomatic Approach in Patients Wit…Concluído
PHASE2🇮🇹 Itália
NCT00140829 · SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias …Concluído
Algeria · 🇧🇪 Bélgica · 🇩🇰 Dinamarca +12
NCT00034242 · High-Dose Intravenous Immunoglobulin to Treat Cerebellar Deg…Concluído
PHASE2🇺🇸 Estados Unidos
NCT00006492 · Gluten-Free Diet in Patients With Gluten Sensitivity and Cer…Concluído
🇺🇸 Estados Unidos
NCT06267222 · Trans-spinal Electrical Stimulation in Individuals With Spin…UNKNOWN
NA🇧🇷 Brasil
NCT04039048 · Effect of ctDCS During Balance Training on Cerebellar AtaxiaUNKNOWN
NA🇧🇷 Brasil
NCT03703830 · tDCS Associated With Locomotor Training on Functional Mobili…UNKNOWN
NA🇧🇷 Brasil
NCT03341416 · Effects of Deep Brain Stimulation of the Dentate Nucleus on …UNKNOWN
NA🇧🇷 Brasil
NCT03213106 · Cerebellar Non-invasive Stimulation in AtaxiasUNKNOWN
NA🇧🇷 Brasil
NCT06324877 · Ataxia-telangiectasia: Treating Mitochondrial Dysfunction Wi…UNKNOWN
NA🇦🇺 Austrália
NCT06183970 · Recovery of Motor Skills With the Use of Artificial Intellig…UNKNOWN
NA
NCT05625620 · Cerebellar-spinal Transcranial Pulsed Current Stimulation (t…UNKNOWN
NA🇨🇦 Canadá
NCT05132647 · Circular Timed Up and Go (cTUG) for Ataxia: Development and …UNKNOWN
Hong Kong
NCT05157802 · Promoting Physical Activity Engagement for People With Early…UNKNOWN
PHASE1🇺🇸 Estados Unidos
NCT04830904 · Efficacy of Lycra Garments in Ataxic SubjectsUNKNOWN
NA🇮🇹 Itália
NCT04297540 · Neuromodulation of Social Skills in Childhood AtaxiaUNKNOWN
NA
NCT04106596 · HLA Analysis in Autoimmune Encephalitis and Related Disorder…UNKNOWN
🇫🇷 França
NCT04092556 · tDCS for Multiple System Atrophy With Cerebellar FeatureUNKNOWN
NASouth Korea
NCT04054726 · A Study on Cerebello-Spinal tPCS in AtaxiaUNKNOWN
NA🇨🇦 Canadá
NCT03269201 · Brain Network Activation in Patients With Movement DisordersUNKNOWN
🇮🇱 Israel
NCT05024240 · Interaction of the Cognitive and Sensory-cognitive Tasks Wit…UNKNOWN
NA🇨🇿 Tchéquia
NCT01958177 · Clinical Study to Evaluate the Safety and Efficacy BMMNC in …UNKNOWN
PHASE1, PHASE2🇮🇳 Índia
NCT01489267 · A New Method to Treat Hereditary Cerebellar Ataxia - Umbilic…UNKNOWN
PHASE2🇨🇳 China
NCT03901638 · Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patien…Encerrado
PHASE3🇹🇼 Taiwan
NCT02566759 · A TAK-831-1001, Single and Multiple Rising Dose Study in Hea…Encerrado
PHASE1🇬🇧 Reino Unido
NCT04301284 · Study of CAD-1883 for Spinocerebellar AtaxiaCancelado
PHASE2🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
2 papers (10 anos)
#1

Spino-cerebellar Ataxia 31 presenting as a demyelinating disease: a case report.

Acta neurologica Belgica2026 Feb

Spinocerebellar ataxia (SCA) is a group of inherited disorders that encompasses different types and presentations. One of its types, SCA31, is a rare ataxia that has a wide spectrum of presentations. Therefore, it may be mistakenly diagnosed with another neurological disorder. Here we describe a 52-year-old woman with progressive imbalance and lower limb weakness who was initially diagnosed with multiple sclerosis (MS) based on periventricular MRI lesions and cerebrospinal fluid oligoclonal bands. She received interferon-beta for four years without improvement. After mistreatment for years, she was reassessed and, due to a strong family history of similar ataxic symptoms, was prompted to undergo genetic testing, which confirmed SCA31. This case highlights the diagnostic challenges associated with SCA31 that can mimic MS because of overlapping clinical and radiological features, potentially leading to misdiagnosis and inappropriate treatment. Therefore, clinicians should exercise caution and consider alternative diagnoses, particularly in the presence of poor response to immunotherapy, a progressive disease course, and a positive family history, all of which may indicate an inherited ataxia.

#2

Identification of a Novel GRM1 Frameshift Variant in Two Pakistani Families Broadens the Genetic Landscape of Ultra-Rare Spinocerebellar Ataxia Type 13.

Cerebellum (London, England)2025 Aug 27

Autosomal recessive spinocerebellar ataxia 13 (SCAR13) is an extremely rare neurodegenerative disorder characterized by psychomotor delay, ranging from mild to severe intellectual disability with absent or poor speech development, nystagmus and stance ataxia. If ambulation is achieved, affected subjects often exhibit gait ataxia. Additionally, epilepsy and polyneuropathy have been reported in some patients. SCAR13 is caused by pathogenic variants in the GRM1 gene, which is predominantly expressed in the cerebellum, with lower levels in the other parts of the brain. To date, only seven reports of this rare ataxia have been published globally. Our study aimed to investigate clinical and mutation spectrum of GRM1-associated SCAR13 disorder in nine patients of two consanguineous Pakistani families (designated here to as NP35 and NP36). We performed whole exome sequencing in the probands of the two families followed by Sanger sequencing to test variant segregation. We identified a novel GRM1 frameshift variant (NM_001278064.2):c.3525_3529del; p.(Asn1176IlefsTer71) in both families as a cause of SCAR13. It was classified as a variant of uncertain significance (PM2: pathogenic moderate 2 and PVS1: pathogenic very strong 1) according to the ACMG guidelines. The novel variant exhibited clinical heterogeneity in the two families. Moreover, scoliosis was observed in all four patients of the family NP35, a feature previously documented in only one patient worldwide. Our study expands the limited mutation spectrum of the GRM1-associated SCAR13. Next-generation sequencing plays a pivotal role in the elucidation of inherited neurological disorders and in a better understanding of the convergent phenotypes.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ataxia rara.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Ataxia rara e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma síndrome neurológica decorrente de problemas no cerebelo e suas conexões ou nas vias sensoriais proprioceptivas. Ela provoca movimentos desajeitados e incoordenação motora dos membros, tronco e músculos da face.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:102002
    Orphanet
  2. GARD:19816
    GARD (NIH)
  3. Q154709
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Ataxia rara. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/ataxia-rara

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Ataxia rara

ORPHA:102002 · MONDO:0000437
CID-10
G11.1 · Ataxia cerebelar de início precoce
Ensaios
18 ativos
Medicamentos
10 registrados
MedGen
UMLS
C0007758
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara